{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:55:37Z","timestamp":1790560537983,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271333"],"award-info":[{"award-number":["82271333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071292"],"award-info":[{"award-number":["82071292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kelin New Talent Program","award":["R08016"],"award-info":[{"award-number":["R08016"]}]},{"name":"Science and Technology Projects in Guangzhou","award":["202201020652"],"award-info":[{"award-number":["202201020652"]}]},{"name":"Guangdong Provincial Clinical Research Center for Neurological Diseases","award":["2020B1111170002"],"award-info":[{"award-number":["2020B1111170002"]}]},{"name":"Guangdong Province International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases","award":["2020A0505020004"],"award-info":[{"award-number":["2020A0505020004"]}]},{"name":"Guangzhou Major Difficult and Rare Diseases Project","award":["2024MDRD02"],"award-info":[{"award-number":["2024MDRD02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10072-026-09419-0","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:55:57Z","timestamp":1790556957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid metabolism in moyamoya disease: Emerging evidence, vascular remodeling, and therapeutic implications"],"prefix":"10.1007","volume":"47","author":[{"given":"Xinglin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-4188","authenticated-orcid":false,"given":"Xunsha","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"4","key":"9419_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K et al (2022) 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo) 62(4):165\u2013170. https:\/\/doi.org\/10.2176\/jns-nmc.2021-0382","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"2","key":"9419_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1570159X19666210716114016","volume":"20","author":"X Zhang","year":"2022","unstructured":"Zhang X, Xiao W, Zhang Q, Xia D, Gao P, Su J et al (2022) Progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment. Curr Neuropharmacol 20(2):292\u2013308. https:\/\/doi.org\/10.2174\/1570159X19666210716114016","journal-title":"Curr Neuropharmacol"},{"issue":"7","key":"9419_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T et al (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6(7):e22542. https:\/\/doi.org\/10.1371\/journal.pone.0022542","journal-title":"PLoS One"},{"issue":"4","key":"9419_CR4","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/STROKEAHA.120.032691","volume":"53","author":"V Roy","year":"2022","unstructured":"Roy V, Ross JP, P\u00e9pin R, Cortez Ghio S, Brodeur A, Touzel Desch\u00eanes L et al (2022) Moyamoya disease susceptibility gene RNF213 regulates endothelial barrier function. Stroke 53(4):1263\u20131275. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032691","journal-title":"Stroke"},{"issue":"11","key":"9419_CR5","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1177\/0271678X221110679","volume":"42","author":"L Zhang","year":"2022","unstructured":"Zhang L, Rashad S, Zhou Y, Niizuma K, Tominaga T (2022) RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses. J Cereb Blood Flow Metab 42(11):2107\u20132122. https:\/\/doi.org\/10.1177\/0271678X221110679","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"9419_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1083\/jcb.201712120","volume":"218","author":"M Sugihara","year":"2019","unstructured":"Sugihara M, Morito D, Ainuki S, Hirano Y, Ogino K, Kitamura A et al (2019) The AAA+ ATPase\/ubiquitin ligase mysterin stabilizes cytoplasmic lipid droplets. J Cell Biol 218(3):949\u2013960. https:\/\/doi.org\/10.1083\/jcb.201712120","journal-title":"J Cell Biol"},{"issue":"1","key":"9419_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.molcel.2019.01.036","volume":"74","author":"M Piccolis","year":"2019","unstructured":"Piccolis M, Bond LM, Kampmann M, Pulimeno P, Chitraju C, Jayson CBK et al (2019) Probing the global cellular responses to lipotoxicity caused by saturated fatty acids. Mol Cell 74(1):32\u201344e8. https:\/\/doi.org\/10.1016\/j.molcel.2019.01.036","journal-title":"Mol Cell"},{"issue":"6","key":"9419_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/svn-2024-003970","volume":"10","author":"Y Mineharu","year":"2025","unstructured":"Mineharu Y, Kamata T, Tomoto M, Sato N, Tamada Y, Funaki T et al (2025) Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya disease. Stroke Vasc Neurol 10(6):752\u2013763. https:\/\/doi.org\/10.1136\/svn-2024-003970","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"9419_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0182-9","volume":"7","author":"TA Lydic","year":"2018","unstructured":"Lydic TA, Goo Y (2018) Lipidomics unveils the complexity of the lipidome in metabolic diseases. Clin Transl Med 7(1):4. https:\/\/doi.org\/10.1186\/s40169-018-0182-9","journal-title":"Clin Transl Med"},{"issue":"18","key":"9419_CR10","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, Shaw JL, Haigis MC, Greka A (2021) Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell 81(18):3708\u20133730. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.027","journal-title":"Mol Cell"},{"key":"9419_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert J, Lehrke M, Marx N, Jankowski J, Noels H (2020) Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev 159:4\u201333. https:\/\/doi.org\/10.1016\/j.addr.2020.07.019","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"9419_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","volume":"10","author":"IJ Neeland","year":"2024","unstructured":"Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE et al (2024) Metabolic syndrome. Nat Rev Dis Primers 10(1):77. https:\/\/doi.org\/10.1038\/s41572-024-00563-5","journal-title":"Nat Rev Dis Primers"},{"key":"9419_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","volume":"159","author":"LM Butler","year":"2020","unstructured":"Butler LM, Perone Y, Dehairs J, Lupien LE, de Laat V, Talebi A et al (2020) Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv Drug Deliv Rev 159:245\u2013293. https:\/\/doi.org\/10.1016\/j.addr.2020.07.013","journal-title":"Adv Drug Deliv Rev"},{"issue":"37","key":"9419_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9317","volume":"8","author":"JH Yoon","year":"2022","unstructured":"Yoon JH, Seo Y, Jo YS, Lee S, Cho E, Cazenave-Gassiot A et al (2022) Brain lipidomics: from functional landscape to clinical significance. Sci Adv 8(37):eadc9317. https:\/\/doi.org\/10.1126\/sciadv.adc9317","journal-title":"Sci Adv"},{"issue":"18","key":"9419_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186651","volume":"21","author":"M Segatto","year":"2020","unstructured":"Segatto M, Pallottini V (2020) Facts about fats: new insights into the role of lipids in metabolism, disease and therapy. Int J Mol Sci 21(18):6651. https:\/\/doi.org\/10.3390\/ijms21186651","journal-title":"Int J Mol Sci"},{"issue":"16","key":"9419_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612744","volume":"24","author":"A Potenza","year":"2023","unstructured":"Potenza A, Gorla G, Carrozzini T, Bersano A, Gatti L, Pollaci G (2023) Lipidomic approaches in common and rare cerebrovascular diseases: the discovery of unconventional lipids as novel biomarkers. Int J Mol Sci 24(16):12744. https:\/\/doi.org\/10.3390\/ijms241612744","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9419_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70054","volume":"6","author":"S He","year":"2025","unstructured":"He S, Zhou Z, Cheng MY, Hao X, Chiang T, Wang Y et al (2025) Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions. MedComm 6(2):e70054. https:\/\/doi.org\/10.1002\/mco2.70054","journal-title":"MedComm"},{"issue":"7","key":"9419_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"9419_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"1","key":"9419_CR20","first-page":"28","volume":"37","author":"AJ Wang","year":"2024","unstructured":"Wang AJ, Zhang N, Li N, Yang T, Li DX, Xia CY (2024) Characteristics of lipid metabolism and its clinical significance in patients with moyamoya disease [in Chinese]. Chin J Stereotact Funct Neurosurg 37(1):28\u201332","journal-title":"Chin J Stereotact Funct Neurosurg"},{"issue":"7","key":"9419_CR21","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/STROKEAHA.111.000307","volume":"44","author":"RS Bower","year":"2013","unstructured":"Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB (2013) Moyamoya disease in a primarily White, Midwestern US population: increased prevalence of autoimmune disease. Stroke 44(7):1997\u20131999. https:\/\/doi.org\/10.1161\/STROKEAHA.111.000307","journal-title":"Stroke"},{"issue":"10","key":"9419_CR22","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1161\/STROKEAHA.120.030653","volume":"51","author":"Y Hirano","year":"2020","unstructured":"Hirano Y, Miyawaki S, Imai H, Hongo H, Ohara K, Dofuku S et al (2020) Association between the onset pattern of adult moyamoya disease and risk factors for stroke. Stroke 51(10):3124\u20133128. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030653","journal-title":"Stroke"},{"issue":"1","key":"9419_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41598-023-47984-y","volume":"14","author":"JH Kim","year":"2024","unstructured":"Kim JH, Jeon H, Kim M, Byun J, Chung Y, Lee SU et al (2024) Chemical and perfusion markers as predictors of moyamoya disease progression and complication types. Sci Rep 14(1):56. https:\/\/doi.org\/10.1038\/s41598-023-47984-y","journal-title":"Sci Rep"},{"key":"9419_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.891622","volume":"13","author":"X Yu","year":"2022","unstructured":"Yu X, Ge P, Zhai Y, Wang R, Zhang Y, Zhang D (2022) Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease. Front Neurol 13:891622. https:\/\/doi.org\/10.3389\/fneur.2022.891622","journal-title":"Front Neurol"},{"issue":"1","key":"9419_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12944-024-02065-5","volume":"23","author":"B Zhang","year":"2024","unstructured":"Zhang B, Li J, Zeng C, Tao C, He Q, Liu C et al (2024) Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with moyamoya disease: a prospective cohort study. Lipids Health Dis 23(1):80. https:\/\/doi.org\/10.1186\/s12944-024-02065-5","journal-title":"Lipids Health Dis"},{"issue":"1","key":"9419_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02015-1","volume":"23","author":"X Chen","year":"2024","unstructured":"Chen X, Song C, Ma X, Tao J, Hu L, Xu Y et al (2024) High lipoprotein(a) concentration is associated with moyamoya disease. Lipids Health Dis 23(1):21. https:\/\/doi.org\/10.1186\/s12944-024-02015-1","journal-title":"Lipids Health Dis"},{"issue":"10459","key":"9419_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","volume":"404","author":"BG Nordestgaard","year":"2024","unstructured":"Nordestgaard BG, Langsted A (2024) Lipoprotein(a) and cardiovascular disease. Lancet 404(10459):1255\u20131264. https:\/\/doi.org\/10.1016\/S0140-6736(24)01308-4","journal-title":"Lancet"},{"issue":"5","key":"9419_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70441","volume":"31","author":"C Zeng","year":"2025","unstructured":"Zeng C, Chen H, Liu J, Bao Y, Sun X, Meng F et al (2025) Unraveling the dyslipidemic landscape in moyamoya disease: oxLDL as a key biomarker. CNS Neurosci Ther 31(5):e70441. https:\/\/doi.org\/10.1111\/cns.70441","journal-title":"CNS Neurosci Ther"},{"issue":"24","key":"9419_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413292","volume":"25","author":"S Thangasparan","year":"2024","unstructured":"Thangasparan S, Kamisah Y, Ugusman A, Mohamad Anuar NN, Ibrahim NI (2024) Unravelling the mechanisms of oxidised low-density lipoprotein in cardiovascular health: current evidence from in vitro and in vivo studies. Int J Mol Sci 25(24):13292. https:\/\/doi.org\/10.3390\/ijms252413292","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9419_CR30","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3171\/2015.5.JNS142973","volume":"124","author":"D Jang","year":"2016","unstructured":"Jang D, Huh PW, Lee K (2016) Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study. J Neurosurg 124(6):1738\u20131745. https:\/\/doi.org\/10.3171\/2015.5.JNS142973","journal-title":"J Neurosurg"},{"issue":"1","key":"9419_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20(1):68\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(20)30412-9","journal-title":"Lancet Neurol"},{"issue":"12","key":"9419_CR32","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.028","volume":"26","author":"D Kashiwazaki","year":"2017","unstructured":"Kashiwazaki D, Uchino H, Kuroda S (2017) Downregulation of apolipoprotein E and apolipoprotein J in moyamoya disease: a proteome analysis of cerebrospinal fluid. J Stroke Cerebrovasc Dis 26(12):2981\u20132987. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.07.028","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"9419_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00566-4","volume":"17","author":"R Fern\u00e1ndez-Calle","year":"2022","unstructured":"Fern\u00e1ndez-Calle R, Konings SC, Fronti\u00f1\u00e1n-Rubio J, Garc\u00eda-Revilla J, Camprub\u00ed-Ferrer L, Svensson M et al (2022) APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol Neurodegener 17(1):62. https:\/\/doi.org\/10.1186\/s13024-022-00566-4","journal-title":"Mol Neurodegener"},{"issue":"6","key":"9419_CR34","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","volume":"26","author":"JW Blanchard","year":"2020","unstructured":"Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A et al (2020) Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med 26(6):952\u2013963. https:\/\/doi.org\/10.1038\/s41591-020-0886-4","journal-title":"Nat Med"},{"issue":"10","key":"9419_CR35","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1038\/s41594-025-01631-4","volume":"32","author":"P Yuste-Checa","year":"2025","unstructured":"Yuste-Checa P, Carvajal AI, Mi C, Paatz S, Hartl FU, Bracher A (2025) Structural analyses define the molecular basis of clusterin chaperone function. Nat Struct Mol Biol 32(10):2035\u20132045. https:\/\/doi.org\/10.1038\/s41594-025-01631-4","journal-title":"Nat Struct Mol Biol"},{"issue":"7889","key":"9419_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-021-04183-x","volume":"600","author":"Z De Miguel","year":"2021","unstructured":"De Miguel Z, Khoury N, Betley MJ, Lehallier B, Willoughby D, Olsson N et al (2021) Exercise plasma boosts memory and dampens brain inflammation via clusterin. Nature 600(7889):494\u2013499. https:\/\/doi.org\/10.1038\/s41586-021-04183-x","journal-title":"Nature"},{"issue":"1","key":"9419_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3340\/jkns.2010.48.1.8","volume":"48","author":"E Koh","year":"2010","unstructured":"Koh E, Kim H, Ma T, Choi H, Kwak Y (2010) Comparative analysis of serum proteomes of moyamoya disease and normal controls. J Korean Neurosurg Soc 48(1):8\u201313. https:\/\/doi.org\/10.3340\/jkns.2010.48.1.8","journal-title":"J Korean Neurosurg Soc"},{"key":"9419_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1156894","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Xu J, Sun J, Duan J, Xiao J, Ren Q et al (2023) APOE as potential biomarkers of moyamoya disease. Front Neurol 14:1156894. https:\/\/doi.org\/10.3389\/fneur.2023.1156894","journal-title":"Front Neurol"},{"issue":"12","key":"9419_CR39","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s12031-022-02092-w","volume":"72","author":"Z Wang","year":"2022","unstructured":"Wang Z, Ji C, Han Q, Wang Z, Huang Y (2022) Data-independent acquisition-based serum proteomic profiling of adult moyamoya disease patients reveals the potential pathogenesis of vascular changes. J Mol Neurosci 72(12):2473\u20132485. https:\/\/doi.org\/10.1007\/s12031-022-02092-w","journal-title":"J Mol Neurosci"},{"issue":"24","key":"9419_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413410","volume":"22","author":"M Dei Cas","year":"2021","unstructured":"Dei Cas M, Carrozzini T, Pollaci G, Potenza A, Nava S, Canavero I et al (2021) Plasma lipid profiling contributes to untangle the complexity of moyamoya arteriopathy. Int J Mol Sci 22(24):13410. https:\/\/doi.org\/10.3390\/ijms222413410","journal-title":"Int J Mol Sci"},{"issue":"16","key":"9419_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165763","volume":"21","author":"F Tinelli","year":"2020","unstructured":"Tinelli F, Nava S, Arioli F, Bedini G, Scelzo E, Lisini D et al (2020) Vascular remodeling in moyamoya angiopathy: from peripheral blood mononuclear cells to endothelial cells. Int J Mol Sci 21(16):5763. https:\/\/doi.org\/10.3390\/ijms21165763","journal-title":"Int J Mol Sci"},{"issue":"17","key":"9419_CR42","doi-asserted-by":"publisher","first-page":"5152","DOI":"10.1111\/febs.16076","volume":"289","author":"J Inokuchi","year":"2022","unstructured":"Inokuchi J, Kanoh H, Inamori K, Nagafuku M, Nitta T, Fukase K (2022) Homeostatic and pathogenic roles of the GM3 ganglioside. FEBS J 289(17):5152\u20135165. https:\/\/doi.org\/10.1111\/febs.16076","journal-title":"FEBS J"},{"key":"9419_CR43","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3389\/fimmu.2020.01305","volume":"11","author":"HS Kim","year":"2020","unstructured":"Kim HS, Han M, Park IH, Park CH, Kwak MS, Shin J (2020) Sulfatide inhibits HMGB1 secretion by hindering Toll-like receptor 4 localization within lipid rafts. Front Immunol 11:1305. https:\/\/doi.org\/10.3389\/fimmu.2020.01305","journal-title":"Front Immunol"},{"issue":"5","key":"9419_CR44","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3171\/2017.5.JNS17147","volume":"129","author":"JW Choi","year":"2018","unstructured":"Choi JW, Son SM, Mook-Jung I, Moon YJ, Lee JY, Wang K et al (2018) Mitochondrial abnormalities related to the dysfunction of circulating endothelial colony-forming cells in moyamoya disease. J Neurosurg 129(5):1151\u20131159. https:\/\/doi.org\/10.3171\/2017.5.JNS17147","journal-title":"J Neurosurg"},{"issue":"10","key":"9419_CR45","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.trecan.2023.07.001","volume":"9","author":"AH Janneh","year":"2023","unstructured":"Janneh AH, Atkinson C, Tomlinson S, Ogretmen B (2023) Sphingolipid metabolism and complement signaling in cancer progression. Trends Cancer 9(10):782\u2013787. https:\/\/doi.org\/10.1016\/j.trecan.2023.07.001","journal-title":"Trends Cancer"},{"issue":"8","key":"9419_CR46","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/CIRCRESAHA.123.323826","volume":"134","author":"OL Manzo","year":"2024","unstructured":"Manzo OL, Nour J, Sasset L, Marino A, Rubinelli L, Palikhe S et al (2024) Rewiring endothelial sphingolipid metabolism to favor S1P over ceramide protects from coronary atherosclerosis. Circ Res 134(8):990\u20131005. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.323826","journal-title":"Circ Res"},{"key":"9419_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108415","volume":"246","author":"S Yaginuma","year":"2023","unstructured":"Yaginuma S, Omi J, Kano K, Aoki J (2023) Lysophospholipids and their producing enzymes: their pathological roles and potential as pathological biomarkers. Pharmacol Ther 246:108415. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108415","journal-title":"Pharmacol Ther"},{"issue":"12","key":"9419_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1492","volume":"13","author":"S He","year":"2023","unstructured":"He S, Wang Y, Liu Z, Zhang J, Hao X, Wang X et al (2023) Metabolomic signatures associated with pathological angiogenesis in moyamoya disease. Clin Transl Med 13(12):e1492. https:\/\/doi.org\/10.1002\/ctm2.1492","journal-title":"Clin Transl Med"},{"issue":"1","key":"9419_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13023-025-03782-5","volume":"20","author":"A Potenza","year":"2025","unstructured":"Potenza A, Gorla G, Carrozzini T, Pollaci G, Dei Cas M, Acerbi F et al (2025) Lipidomic profiling of the cerebrospinal fluid in moyamoya angiopathy patients. Orphanet J Rare Dis 20(1):243. https:\/\/doi.org\/10.1186\/s13023-025-03782-5","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"9419_CR50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20241232","volume":"222","author":"V Tiwari","year":"2025","unstructured":"Tiwari V, Simons M (2025) Lipid metabolism and neuroinflammation: what is the link? J Exp Med 222(9):e20241232. https:\/\/doi.org\/10.1084\/jem.20241232","journal-title":"J Exp Med"},{"issue":"1","key":"9419_CR51","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/JS9.0000000000002092","volume":"111","author":"K He","year":"2025","unstructured":"He K, Wang X, Gu Y, Tong X, Qin X, Liao Y et al (2025) In-depth cerebrovascular lipidomics profiling for discovering novel biomarkers and mechanisms in moyamoya and intracranial atherosclerotic disease. Int J Surg 111(1):1607\u20131613. https:\/\/doi.org\/10.1097\/JS9.0000000000002092","journal-title":"Int J Surg"},{"issue":"20","key":"9419_CR52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI161366","volume":"133","author":"E Sj\u00f6berg","year":"2023","unstructured":"Sj\u00f6berg E, Melssen M, Richards M, Ding Y, Chanoca C, Chen D et al (2023) Endothelial VEGFR2-PLC\u03b3 signaling regulates vascular permeability and antitumor immunity through eNOS\/Src. J Clin Invest 133(20):e161366. https:\/\/doi.org\/10.1172\/JCI161366","journal-title":"J Clin Invest"},{"key":"9419_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56185","volume":"9","author":"J Ahel","year":"2020","unstructured":"Ahel J, Lehner A, Vogel A, Schleiffer A, Meinhart A, Haselbach D et al (2020) Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism. eLife 9:e56185. https:\/\/doi.org\/10.7554\/eLife.56185","journal-title":"eLife"},{"key":"9419_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145340","volume":"771","author":"P Sarkar","year":"2021","unstructured":"Sarkar P, Thirumurugan K (2021) New insights into TNF\u03b1\/PTP1B and PPAR\u03b3 pathway through RNF213- a link between inflammation, obesity, insulin resistance, and moyamoya disease. Gene 771:145340. https:\/\/doi.org\/10.1016\/j.gene.2020.145340","journal-title":"Gene"},{"issue":"8","key":"9419_CR55","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1161\/STROKEAHA.120.030027","volume":"51","author":"P Ge","year":"2020","unstructured":"Ge P, Zhang Q, Ye X, Liu X, Deng X, Wang J et al (2020) Modifiable risk factors associated with moyamoya disease: a case-control study. Stroke 51(8):2472\u20132479. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030027","journal-title":"Stroke"},{"issue":"3","key":"9419_CR56","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2021.6.FOCUS21112","volume":"51","author":"Q Wang","year":"2021","unstructured":"Wang Q, Bao X, Zou Z, Wang X, Zhang Q, Li D et al (2021) The role of atorvastatin in collateral circulation formation induced by encephaloduroarteriosynangiosis: a prospective trial. Neurosurg Focus 51(3):E9. https:\/\/doi.org\/10.3171\/2021.6.FOCUS21112","journal-title":"Neurosurg Focus"},{"issue":"1","key":"9419_CR57","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s42003-022-03081-w","volume":"5","author":"J Yang","year":"2022","unstructured":"Yang J, Sun M, Cheng R, Tan H, Liu C, Chen R et al (2022) Pitavastatin activates mitophagy to protect EPC proliferation through a calcium-dependent CAMK1-PINK1 pathway in atherosclerotic mice. Commun Biol 5(1):124. https:\/\/doi.org\/10.1038\/s42003-022-03081-w","journal-title":"Commun Biol"},{"issue":"4","key":"9419_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/svn-2022-001985","volume":"8","author":"J Yoo","year":"2023","unstructured":"Yoo J, Jeon J, Baik M, Kim J (2023) Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study. Stroke Vasc Neurol 8(4):276\u2013283. https:\/\/doi.org\/10.1136\/svn-2022-001985","journal-title":"Stroke Vasc Neurol"},{"issue":"1","key":"9419_CR59","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s10020-024-01025-0","volume":"30","author":"J Liu","year":"2024","unstructured":"Liu J, Lei S, Zhang D, He Q, Sun Y, Zhu H et al (2024) The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood-brain barrier protection. Mol Med 30(1):256. https:\/\/doi.org\/10.1186\/s10020-024-01025-0","journal-title":"Mol Med"},{"issue":"6","key":"9419_CR60","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","volume":"97","author":"CA German","year":"2023","unstructured":"German CA, Liao JK (2023) Understanding the molecular mechanisms of statin pleiotropic effects. Arch Toxicol 97(6):1529\u20131545. https:\/\/doi.org\/10.1007\/s00204-023-03492-6","journal-title":"Arch Toxicol"},{"issue":"2","key":"9419_CR61","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s10072-021-05359-z","volume":"43","author":"Z Chen","year":"2022","unstructured":"Chen Z, Wu X, Zhou D, Shang S, Ding Y, Ji X et al (2022) Characteristics of cerebral ischemic stroke based on moyamoya disease and atherosclerosis-associated intracranial arterial stenosis. Neurol Sci 43(2):1087\u20131096. https:\/\/doi.org\/10.1007\/s10072-021-05359-z","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09419-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09419-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09419-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:55:59Z","timestamp":1790556959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09419-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9419"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09419-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"818"}}